Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Reem Karmali"'
Autor:
Timothy S. Fenske, Jin Guo, Brian T. Hill, Natalie S Grover, Krithika Shanmugasundaram, Madelyn Burkart, Brad S. Kahl, Stefan K. Barta, J. Switchenko, Alexey V. Danilov, Subir Goyal, Mehdi Hamadani, Max J. Gordon, Christopher R. Flowers, Oscar Calzada, Peter Martin, David A. Bond, Jonathon B. Cohen, Yazeed Sawalha, Nilanjan Ghosh, Steven I. Park, Kristie A. Blum, James N. Gerson, Bhaskar Kolla, Reem Karmali, Stephanie Mathews, Michael C. Churnetski, Talha Badar, Veronika Bachanova, Mary Malecek, Narendranath Epperla
Publikováno v:
Eur J Haematol
INTRODUCTION: While most patients with mantle cell lymphoma (MCL) receive therapy shortly after diagnosis, a subset of patients with indolent-behaving disease can safely defer treatment. In this subgroup, we evaluated the importance of treatment inte
Autor:
Craig A. Portell, Seo-Hyun Kim, Catherine Wei, Neil Palmisiano, Catherine Diefenbach, Manali Kamdar, Madelyn Burkart, Nadia Khan, Seth M. Maliske, Izidore S. Lossos, Andreas K. Klein, Paolo Caimi, Narendranath Epperla, Amandeep Godara, Alexey V. Danilov, Victor M. Orellana-Noia, Max J. Gordon, Adam Zayac, Maryam Sarraf Yazdy, Allandria Straker-Edwards, Michael C. Churnetski, Ayushi Chauhan, Umar Farooq, Deepa Jagadeesh, Daulath Singh, Matthew A. Lunning, Suchitra Sundaram, Sarah Stettner, Kirsten M Boughan, Lori A. Leslie, Yusra F. Shao, Peter Martin, Amy Sperling, Stephen D. Smith, Reem Karmali, Bradley M. Haverkos, Parameswaran Venugopal, Veronika Bachanova, Tycel Phillips, Yun Kyong Choi, Malvi Savani, Seema Naik, Gaurav Varma, Vaishalee P. Kenkre, Gabriella Magarelli, Ryan Vaca, Asaad Trabolsi, Andrew M. Evens, Juan Pablo Alderuccio, Emma Rabinovich, Christopher D'Angelo, Nishitha Reddy, Adam J. Olszewski, Kristie A. Blum, Stephanie Berg, David A. Bond, Kevin A. David
Publikováno v:
Haematologica. 106:1932-1942
Central nervous system (CNS) involvement in Burkitt lymphoma (BL) poses a major therapeutic challenge, and the relative ability of contemporary regimens to treat CNS involvement remains uncertain. We described prognostic significance of CNS involveme
Autor:
Craig S. Sauter, Farrukh T. Awan, Kwang Woo Ahn, Mohamed A. Kharfan-Dabaja, Manoj Khanal, Timothy S. Fenske, Victor A. Chow, Reem Karmali, Alireza Eghtedar, Allison M. Winter, Mehdi Hamadani, Carlos Litovich
Publikováno v:
Biol Blood Marrow Transplant
Disease relapse is the most common cause of therapy failure in patients with non-Hodgkin lymphoma (NHL) undergoing reduced-intensity conditioning (RIC) allogeneic hematopoietic cell transplantation (allo-HCT). It is not known whether or not increasin
Autor:
James Godfrey, Pallawi Torka, Sonali M. Smith, Suman Paul, Madelyn Burkart, Raoul Santiago, Robert T. Chen, Ranjana H. Advani, Frederick Lansigan, Alex F. Herrera, Catherine Wei, Julio C. Chavez, Sarit Assouline, Reem Karmali, Kevin A. David, N Nina Wagner-Johnston, Catherine Diefenbach, Jakub Svoboda, Steven M. Bair, Sarah Tomassetti, Yang Liu, Daniel O. Persky, Lukas Emery, Sunita Nathan, Reid W. Merryman, Nicole A. Carreau, Muhammad Hamid, Andrea B. Troxel, Philippe Armand, Stefan K. Barta, Radhakrishnan Ramchandren, Jonathan B. Cohen, Michael A. Spinner
Publikováno v:
Oncologist
Atypical response patterns following immune checkpoint blockade (ICB) in Hodgkin lymphoma (HL) led to the concept of continuation of treatment beyond progression (TBP); however, the longitudinal benefit of this approach is unclear. We therefore perfo
Autor:
David A. Bond, Angel Mier Hicks, Amir Behdad, Pallawi Torka, Daniel J. Landsburg, Nina D. Wagner-Johnston, Julio C. Chavez, Kami J. Maddocks, Reem Karmali, Rawan Faramand, Radhakrishnan Ramchandren, Emily C. Ayers, Madeira Curry, Dipenkumar Modi, L. Jeffrey Medeiros, Sarit Assouline, Shaoying Li
Publikováno v:
British Journal of Haematology. 189:313-317
While patients with double-hit lymphoma (DHL) are now frequently treated with intensive front-line immunochemotherapy, outcomes for those who fail these regimens and subsequently receive curative-intent second-line immunochemotherapy are unknown. We
Autor:
Angel Mier Hicks, Julio C. Chavez, Amir Behdad, Emily C. Ayers, Jonathon B. Cohen, Daniel J. Landsburg, Catherine Diefenbach, Victor M. Orellana-Noia, Bita Fakhri, Michael C. Churnetski, Anshu Giri, Shaoying Li, Kami J. Maddocks, Rawan Faramand, Brian T. Hill, Christina Howlett, Jennifer E Amengual, Helen Ma, Craig A. Portell, Brian T. Hess, Yang Liu, Reem Karmali, Pallawi Torka, Adam J. Olszewski, Samuel Cytryn, Sarit Assouline, Madeira Curry, Radhakrishnan Ramchandren, Nishitha Reddy, Brad S. Kahl, Stefan K. Barta, Nina D. Wagner-Johnston, L. Jeffrey Medeiros, Dipenkumar Modi, David A. Bond, Ashwin Chandar, Lori A. Leslie, Dhruvika Mukhija, Kevin A. David, Sunita Nathan
Publikováno v:
Cancer. 126:293-303
BACKGROUND Salvage immunochemotherapy followed by high-dose chemotherapy and autologous stem cell transplantation is the standard-of-care second-line treatment for patients with relapsed/refractory diffuse large B-cell lymphoma after first-line R-CHO
Autor:
Kwang Woo Ahn, Mohamed A. Kharfan-Dabaja, Nirav N. Shah, Farhad Khimani, Praveen Ramakrishnan Geethakumari, Sairah Ahmed, Yue Chen, Sachiko Seo, Nilanjan Ghosh, Narendranath Epperla, Mehdi Hamadani, Sanghee Hong, Amer Beitinjaneh, Pashna N. Munshi, Tim Prestidge, Leona Holmberg, Victor A. Chow, Michael Scordo, Yago Nieto, Natalie S Grover, Umar Farooq, Nada Hamad, Reem Karmali, Gerhard C. Hildebrandt, Andrew R. Rezvani, Jean A. Yared, Antonio Jimenez-Jimenez, Maxwell M. Krem, Bhagirathbhai Dholaria, Evgeny Klyuchnikov, Craig S. Sauter, David J. Inwards, Peter A. Riedell, Trent P Wang, Farrukh T. Awan, Alex F. Herrera, Andy I. Chen, Melhem Solh, Vaishalee P. Kenkre
Publikováno v:
JAMA Oncol
IMPORTANCE: Primary central nervous system lymphoma (PCNSL) requires induction and consolidation to achieve potential cure. High-dose therapy and autologous hematopoietic cell transplant (AHCT) is an accepted and effective consolidation strategy for
Publikováno v:
Current gastroenterology reportsPapers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance. 23(7)
Primary GI lymphomas of B cell origin are a diverse group of lymphomas. In this article, we provide an overview of the diagnosis, pathologic and molecular features, and management of these varied lymphomas. The most common primary GI lymphomas are di
Autor:
Yi Hua Chen, Leo I. Gordon, Marissa K. Falkiewicz, Angela J. Fought, Timothy Taxter, Reem Karmali, Qing C. Chen, Craig S. Boddy, Emily C. Ayers, Jason B. Kaplan, Barbara Pro, Amir Behdad, Daniel J. Landsburg, Jane N. Winter
Publikováno v:
Leukemia & Lymphoma. 60:3266-3271
Diffuse large B-cell lymphoma (DLBCL) transformed from follicular lymphoma (FL) (tDLBCL) has been traditionally associated with an aggressive course, but more recent studies have shown longer survivals. The clinical significance of concurrent FL at t
Autor:
Madelyn Burkart, Nishitha Reddy, Suchitra Sundaram, Victor M. Orellana-Noia, Adam Zayac, Andrew M. Evens, Andreas K. Klein, Alessia Dalla Pria, Catherine Diefenbach, Ayushi Chauhan, Kristie A. Blum, Umar Farooq, Frank A. Post, Stephanie Berg, Michael C. Churnetski, Graham P. Collins, Deepa Jagadeesh, Agrima Mian, Alexey V. Danilov, David A. Bond, Yun Kyong Choi, Seema Naik, Vaishalee P. Kenkre, Scott E. Smith, Kirsten M Boughan, Craig A. Portell, Yong Lin, Seth M. Maliske, Izidore S. Lossos, Tatyana Feldman, Andrzej Stadnik, Adam J. Olszewski, Stephen D. Smith, Amandeep Godara, Gaurav Varma, Shireen Kassam, Peter Martin, Christopher D'Angelo, Mark Bower, Albert Ren, Reem Karmali, Narendranath Epperla, Bradley M. Haverkos, Silvia Montoto, Parameswaran Venugopal, Manali Kamdar, Nadia Khan, Kate Cwynarski, Maryam Sarraf Yazdy, Juan Pablo Alderuccio, Catherine Zhu, Amy Sperling, Seo-Hyun Kim, Ryan Vaca, Emma Rabinovich, Daniel Rector, Allandria Straker-Edwards, Catherine Wei, Paolo Caimi
Publikováno v:
Blood Adv
Data addressing prognostication in patients with HIV related Burkitt lymphoma (HIV-BL) currently treated remain scarce. We present an international analysis of 249 (United States: 140; United Kingdom: 109) patients with HIV-BL treated from 2008 to 20